Lower riskDrug recall · FDA · Published December 28, 2022
Eugia Acyclovir Injection Recall: Dark Particles in Vials
Eugia US LLC recalls Acyclovir Sodium Injection vials due to customer reports of dark particles. This may cause injury if injected. Check your vial's lot number and contact the manufacturer for details.
“Eugia Acyclovir Injection Recall: Dark Particles in Vials.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34043-eugia-acyclovir-injection-recall-dark-particles-in-vials. Based on FDA recall #D-0095-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0095-2023%22&limit=1).
Eugia US LLC recalled Acyclovir Sodium Injection distributed by AuroMedics Pharma LLC due to the presence of particulate matter, according to the FDA. The Food and Drug Administration announced the Class II recall on December 28, 2022.
The recall addresses customer complaints of dark particles found inside the vial. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Eugia US LLC has 14 other recalls on record since September 28, 2023. Recent Eugia recalls include a May 18, 2026 Lidocaine injection recall due to label scanning issues and a May 29, 2025 Gentamicin Injection recall due to stability failure. Other recent recalls of similar products include a July 17, 2026 Sunny Pharmtech Cyclophosphamide Injection Recall for stainless steel particulate risk, a May 12, 2026 Sun Pharmaceutical DOXOrubin Liposome Injection Recall for glass particulate risk, and an August 6, 2026 Mallinckrodt Acthar Gel 5mL Vial Recall for particulate matter hazard.
How to tell if you have this one
Check for vials labeled 'Acyclovir Sodium Injection 1,000 mg per 20 mL (50 mg/mL), Single Dose 20mL'. Look for lot number AC22004 with expiry date 08/2023.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Details
Look for the lot number AC22004 and expiry date 08/2023 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0095-2023 (December 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0095-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.